• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Ind-Swift Laboratories Ltd

+ Add to Watchlist

ISL:IN

44.30 INR 0.15 0.34%

As of 07:06:02 ET on 07/30/2014.

Snapshot for Ind-Swift Laboratories Ltd (ISL)

Open: 45.20 Day's Range: 43.65 - 46.40 Volume: 1,957,531
Previous Close: 44.15 52wk Range: 19.25 - 57.60 1-Yr Rtn: +28.03%

Stock Chart for ISL

No chart data available.
  • ISL:IN 44.30
  • 1D
  • 1M
  • 1Y
44.15
Interactive ISL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ISL

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SENSEX -
Earnings Per Share (ttm) -29.1100
Est. EPS -
Est. PEG Ratio -
Market Cap (M INR) 1,814.67
Shares Outstanding (M) 40.96
30 Day Average Volume 611,268
Price/Book (mrq) 0.2502
Price/Sale (ttm) 0.1924
Dividend Indicated Gross Yield -%
Cash Dividend (INR) 1.0000
Dividend Ex-Date 09/20/2011
5 Year Dividend Growth -
Next Earnings Announcement 05/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ISL

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for ISL

Ind-Swift Laboratories Ltd. manufactures bulk drugs and intermediates. The Company's product portfolio includes anti-infective, anti-allergy, analgesic and cardiovascular medicines.

N R MunjalVice Chairman/Mng Dir/CEOHimanshu JainJoint Managing Director
N K BansalChief Financial OfficerLalit K WadhwaChief Operating Officer
More Company Profile & Key Executives for ISL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil